PRACTICE PEARL
This study demonstrates that adding extended-release niacin to statins favorably affects atherosclerotic lesions in the carotid arteries of atherosclerotic coronary heart disease (CHD) patients and moderately low high density lipoprotein cholesterol (HDL-C) levels.